22:21 EDT Lyell Immunopharma (LYEL) files to sell 625,000 shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LYEL:
- Lyell Immunopharma target adjusted to $10 from $1 at H.C. Wainwright
- Lyell Immunopharma Announces Promising CAR T-Cell Trial Data
- Lyell Immunopharma’s LYL314 shows strong response in Phase 1/2 lymphoma trial
- Lyell Immunopharma Expands Board, Appoints New Director
- Lyell Immunopharma appoints David Shook as CMO, Mark Meltz as general counsel